#AIDS2024 Paso Doble! Switch to Biktarvy assoc with sig more weight gain than switch to Dovato +1.8kg vs 0.9kg at W48 p=0.016 aOR for >5% wt gain 1.81 (p=0.006) on Bik Impact of baseline NRTI backbone needs exploration Non-inferior efficacy (with CI trend in favour of Dovato)

“The case of the next Berlin patient has helped energize us as we explore cure strategies based on gene therapy. It’s stories like this that give us – people living with #HIV, clinicians and scientists – hope.” – #AIDS2024 International Co- Chair Sharon Lewin 🇦🇺

Our August issue is ready! Featuring 144 weeks results from DISCOVER open label extension, urine tenofovir assay for #PrEP adherence, intimate partner violence link to vertical #HIV transmission, and more. Available here thelancet.com/issue/S2352-30… Cover: ilustratoro (IG)

Mounting #mpox infections and deaths have led World Health Organization (WHO) to once again declare a Public Health Emergency of International Concern (PHEIC). Today, an Editorial from The Lancet: “Mpox: the need for a coordinated international response” hubs.li/Q02LzxDC0

LONG WAIT: for long-acting HIV prevention and treatment in low-and-middle-income countries led to this article in The Lancet HIV led by Francois Venter - feels very frustrating to be in place where all we talk about in HIV is long-acting without access authors.elsevier.com/c/1jcMh8MsVody…

Long-acting injectables for #HIV prevention and treatment can take us closer than ever to global HIV elimination. Here, Francois Venter & Co. call for coordination among companies, agencies, and donors to launch large-scale implementation programmes now. thelancet.com/journals/lanhi…

1 Thread on #mpox which is in the news again since a returning traveller was diagnosed in Sweden with a new more dangerous strain which reached Europe for the first time. In the 2022-23 global outbreak I was clinical advisor to @WHOEurope Here’s what I think you need to know.